New Agents Aside from GLP-1RA, GIP agonism is also a promising treatment for obesity, with preclinical studies demonstrating improved metabolic profiles and reduced food intake
Garner mentioned that, Its primarily marketed for obesity management rather than weight loss. [3] In December 2024, the FDA approved Zepbound (tirzepatide) as the first and only prescription medicine for moderate-to-severe obstructive sleep apnea in adults with obesity
View Study [4]"The effect of topical tripeptide-copper complex on healing of ischemic open wounds" Canapp SO, Farese JP, Schultz GS, Gowda S, et al., 2003 Finding: Topical GHK-Cu dramatically accelerated wound healingwounds shrank by 64.5% in the treatment group versus only 28.2% in controls by day 13
10.3346/jkms.2021.36.e61 23 Ndzie NoahM
doi: 10.1016/j.pneurobio.2005.06.004 78 MrakREGriffinWST
If youre someone whos trying to manage your weight and improve your health, the good news is that effective treatments are available